Panax Notoginseng.
Notoginseng root brings ginsenosides plus its own marker R1. It's used in Chinese practice to support circulation, normal blood flow and recovery after hard physical work.
- Category
- Herb
What Panax Notoginseng is, and what it does.
- Does it work
- Suits people already using Chinese herbal formulas and anyone wanting a ginseng relative with its own saponin profile. It needs care alongside blood thinners.
- How much to take
- No daily amount is on record for it. Traditional use is a measured spoon of powder or a standardised saponin extract taken daily with food rather than occasionally.
- Time to feel it
- Circulatory and recovery measures in notoginseng research are read across weeks. Traditional use for bruising after exertion runs shorter, over several days.
- The first dose
- Day one is usually uneventful beyond the bitter taste. A few people notice mild stomach unease if they take the raw powder without food.
- With regular use
- Weeks of daily use inside a formula is the traditional pattern. Human trials are mostly short, so the long-run picture rests largely on that traditional record.
- How well tolerated
- Take care alongside blood thinners or before surgery: it carries saponins that reduce platelet clumping plus a compound linked to the opposite effect. Ask your clinician first.
- How it feels
- Bitter and earthy. Most people report nothing dramatic, which is normal here. Effects register in recovery and bruising over days rather than as a same-hour sensation.
- The overlooked benefit
- Steaming changes the chemistry, not just the taste. Heat converts common saponins into rarer ones like Rg3, so steamed and raw root are genuinely different materials.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- circulation and normal blood flowRandomised trial
- platelet aggregation behaviourNarrative review
- recovery after physical exertionAnimal study
- a healthy inflammatory responseAnimal study
- gut conversion of ginsenosides to compound KIn vitro study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Astragalus and notoginseng saponins are a long-standing formula pairing and have been evaluated as a fixed combined extract rather than as separate arms. That design means any result belongs to the combination, and nothing can be assigned to notoginseng on its own. The pairing is real as formulation practice. The attribution is not available.
Protopanaxadiol ginsenosides such as Rb1 are poorly absorbed intact. Colonic bacteria remove sugar units stepwise to yield compound K, which is the species that actually reaches circulation in quantity. People differ several-fold in how efficiently they perform that conversion, and non-converters get much less systemic exposure from the same amount. Whether a specific strain reliably raises conversion in people has not been settled.
Notoginseng saponins reduce platelet aggregation in laboratory and animal work, and high-intake EPA and DHA push in the same direction in people. The combined effect on bleeding tendency is the point worth flagging, not a benefit. This is mechanistic overlap, not a tested combination.
Both have shown antiplatelet activity in laboratory preparations. Neither has been established as producing a clinically meaningful change at ordinary supplement intakes, and the combination has not been studied in people. Listed for direction only.
Notoginseng is unusual in carrying both a haemostatic constituent, dencichine, and antiplatelet saponins, so its net effect on clotting is not one-directional. Vitamin K1 supports gamma-carboxylation of clotting factors on the opposite side of the ledger. Anyone whose clotting is being managed deliberately has a reason to know both are in the mix and to raise it with their prescriber.
Piperine inhibits P-glycoprotein and CYP3A4, and several ginsenosides are P-glycoprotein substrates. In principle that raises exposure to the saponins that do get absorbed. No human pharmacokinetic study has measured this pairing for notoginseng specifically, so the size and even the reliability of the effect are unknown.
Nothing specific on file for Panax Notoginseng. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Panax Notoginseng actually does.
The root is full of saponins. One of them, R1, is found in this species and almost nowhere else, so labs use it to confirm what they have.
Your gut bacteria have to chew the sugars off before much gets into your blood, which is why the same dose does different things in different people.
Steaming the root chemically rearranges the saponins, so steamed and raw are not interchangeable.
The root, rootlet, stem and leaf of this plant have noticeably different saponin makeups, with the above-ground parts richer in different compounds than the root, so it matters which part a product actually uses.
Where Panax Notoginseng comes from.
It is a ginseng relative grown mostly in Yunnan. The root gets dried, sometimes steamed, then extracted and concentrated. R1 is the fingerprint that proves it is this species and not regular ginseng.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Grown mainly in Yunnan and Guangxi under shade, harvested after three years or more. Soil properties and rhizosphere microbial community track with the constituent levels in the harvested root.
Roots are dried whole and graded by head count per unit weight. Steaming, where used, converts the saponin profile toward rare ginsenosides.
Ethanol and water pull the dammarane saponins from the milled root.
Macroporous resin separates the saponin fraction from sugars and polar impurities.
Batches are assayed and blended to a stated combined saponin percentage. R1 confirms the species.
Delivered as graded root powder or as a standardised saponin extract.
The forms it comes in.
The essence, in one line each.
- Participants taking Panax notoginseng before endurance exercise showed improved endurance performance measures compared with the control condition.Randomised trial. Liang MT et al., 2005 (Journal of Strength and Conditioning Research). PMID 15744902 ↗
- Notoginseng saponins reduced markers of diet-induced liver stress in rodents fed a high-fat diet, with the authors proposing lipid-handling mechanisms.Animal study. Li R et al., 2026 (Food Science & Nutrition). PMID 41695106 ↗
- Carbon dots derived from Panax notoginseng reduced kidney injury markers after ischaemia and reperfusion in an animal model.Animal study. Yang M et al., 2026 (Theranostics). PMID 41695479 ↗
- Single-cell multiomics identified vascular cell populations affected in the model, and Panax notoginseng derived vesicles acted on those populations.Animal study. Xia F et al., 2026 (Materials Today Bio). PMID 41560797 ↗
- Stems and leaves of Panax notoginseng altered mRNA expression of TLR signalling pathway components in the animals studied.Animal study. Zhang N et al., 2025 (Genes). PMID 40725434 ↗
- Panax notoginseng processing residue shifted rumen microbial community composition and blood biochemical parameters in the animals studied.Animal study. Wu D et al., 2025 (Animals). PMID 40150317 ↗
- Metagenomic profiling linked rhizosphere microbial community composition and soil properties to the levels of active constituents in the harvested plants.Cohort study. Liang ZW et al., 2026 (Journal of Ginseng Research). PMID 41788574 ↗
These are the studies our verdict leans on, chosen from the 7 we read for Panax Notoginseng. The full linked list is below.
The studies, linked.
8 sources behind our Panax Notoginseng verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialClinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations:A Prospective Randomized Controlled Multi-site Clinical Trial About Fractions-based Herbal Combinations of Clearing Heat and Promoting Blood CirculationClinicalTrials.gov ↗120 participants, Completed
- Clinical trialA Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plus®) on Cholesterol and Blood PressureClinicalTrials.gov ↗Phase 2, 95 participants, Completed
- Clinical trialClinical Study on the Treatment of Hypertensive Cerebral Hemorrhage With Panax Notoginseng SaponinsClinicalTrials.gov ↗Phase 4, 90 participants, Completed
- Clinical trialClinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome After Percutaneous Coronary InterventionClinicalTrials.gov ↗Phase 1, 60 participants, Completed
- Clinical trialClinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome After Percutaneous Coronary InterventionClinicalTrials.gov ↗Phase 3, 400 participants, Not yet recruiting
- Clinical trialHeat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction: Mechanisms of Multi-target Anti-inflammatory ActionClinicalTrials.gov ↗120 participants, Unknown
- ClinicalTrials.gov ↗
- Clinical trialImpact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide in Acute Coronary Syndromes : A Randomized Placebo Controlled TrialClinicalTrials.gov ↗80 participants, Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 12,444 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Panax Notoginseng is, not how risky it is. A report is not proof Panax Notoginseng caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
